Base de dados : HANSEN
Pesquisa : MODELOS ESTATISTICOS [Descritor de assunto]
Referências encontradas : 4 [refinar]
Mostrando: 1 .. 4   no formato [Detalhado]

página 1 de 1

  1 / 4 HANSEN  
              next record last record
seleciona
para imprimir
Id:25256
Autor:Wallace, Chris; Clayton, David
Título:Estimating the relative recurrence risk ratio using a global cross-ratio model
..-
Fonte:s.l; s.n; 2003. 10 p. tab, graf.
Resumo:The relative recurrence risk ratio lambdaR (and particularly the sibling recurrence risk ratio, lambdaS) is often of interest to those wanting to quantify the genetic contribution towards risk of disease or to discriminate between different genetic models. However, estimating lambdaR for complex diseases for which genetic and environmental risk factors are both involved is not straightforward. Ignoring environmental factors may lead to inflated estimates of lambdaR. We present a marginal model which uses a copula function to model the association in cumulative incidence rates between pairs of relatives. This model is applicable to present-state data and allows estimation of risk of disease in a pair of relatives (and hence lambdaR), given measured environmental covariates. We apply the model to leprosy among sibling pairs from the Karonga district, Malawi. If risk factors are ignored, the apparent lambdaS in this population is over 3. Accounting for known nongenetic risk factors reduces it to just under 2. (AU).
Descritores:MODELOS TEORICOS
MODELOS DE RISCOS PROPORCIONAIS
MODELOS LOG-LINEARES (SAUDE PÚBLICA)
MODELOS ESTATISTICOS
HANSENIASE DIMORFA/imunol
HANSENIASE DIMORFA/microbiol
HANSENIASE DIMORFA/transm
HANSENIASE VIRCHOWIANA/imunol
HANSENIASE VIRCHOWIANA/microbiol
HANSENIASE VIRCHOWIANA/transm
HANSENIASE TUBERCULOIDE/imunol
HANSENIASE TUBERCULOIDE/microbiol
HANSENIASE TUBERCULOIDE/transm
HANSENIASE/clas
HANSENIASE/imunol
HANSENIASE/microbiol
HANSENIASE/transm
MODELOS MATEMATICOS
 RAZAO DE DIFERENCA
 RISCO RELATIVO (SAUDE PÚBLICA)
 MEDICAO DE RISCO/estatíst
 MEDICAO DE RISCO/tend
 VACINA BCG/uso terap
 COMUNICANTE/estatíst
Limites:HUMANO
Localização:BR191.1; 00723/s


  2 / 4 HANSEN  
              first record previous record next record last record
seleciona
para imprimir
Id:18571
Autor:Meima, Abraham; Irgens, Lorentz M; Van Oortmarssen, Gerrit J; Richardus, Jan H; Habbema, Dik F
Título:Disappearance of leprosy from Norway: an exploration of critical factors using an epidemiological modelling approach
..-
Fonte:s.l; s.n; 2002. 10 p. ilus, tab, graf.
Resumo:BACKGROUND: By the middle of the 19th century, leprosy was a serious public health problem in Norway. By 1920, new cases only rarely occurred. This study aims to explain the disappearance of leprosy from Norway. METHODS: Data from the National Leprosy Registry of Norway and population censuses were used. The patient data include year of birth, onset of disease, registration, hospital admission, death, and emigration. The Norwegian data were analysed using epidemiological models of disease transmission and control. RESULTS: The time trend in leprosy new case detection in Norway can be reproduced adequately. The shift in new case detection towards older ages which occurred over time is accounted for by assuming that infected individuals may have a very long incubation period. The decline cannot be explained fully by the Norwegian policy of isolation of patients: an autonomous decrease in transmission, reflecting improvements in for instance living conditions, must also be assumed. The estimated contribution of the isolation policy to the decline in new case detection very much depends on assumptions made on build-up of contagiousness during the incubation period and waning of transmission opportunities due to rapid transmission to close contacts. CONCLUSION: The impact of isolation on interruption of transmission remains uncertain. This uncertainty also applies to contemporary leprosy control that mainly relies on chemotherapy treatment. Further research is needed to establish the impact of leprosy interventions on transmission. (AU).
Descritores:SIMULACAO POR COMPUTADOR
HANSENIASE/epidemiol
HANSENIASE/prev
HANSENIASE/transm
ISOLAMENTO DE PACIENTES
NORUEGA/epidemiol
MODELOS ESTATISTICOS
 SISTEMA DE REGISTROS
Limites:HUMANO
CRIANÇA
ADULTO
MEIA-IDADE
IDOSO
ADOLESCENTE
Meio Eletrônico: - .
Localização:BR191.1; 09039/s


  3 / 4 HANSEN  
              first record previous record next record last record
seleciona
para imprimir
Id:14113
Autor:Lietman, Tom; Porco, Travis; Blower, Sally
Título:Leprosy and tuberculosis: the epidemiological consequences of cross-immunity (Commentary)
..-
Fonte:s.l; s.n; 1997. 5 p. ilus.
Descritores:CAUSA DA MORTE
COMORBILIDADE
REAÇOES CRUZADAS
AVANÇO DA DOENÇA
IMUNIDADE ATIVA
INCIDENCIA
HANSENIASE
HANSENIASE
HANSENIASE
MODELOS ESTATISTICOS
REPRODUTIBILIDADE DE RESULTADOS
FATORES DE TEMPO
TUBERCULOSE
TUBERCULOSE
TUBERCULOSE
Localização:BR191.1; 07055/s


  4 / 4 HANSEN  
              first record previous record
seleciona
para imprimir
Id:13990
Autor:Shah, S; Green, J. R
Título:Testing for haplotype concordance with incomplete parental data-madified Q and correction for odified N
..-
Fonte:s.l; s.n; 1993. 9 p. tab.
Descritores:SUSCETIBILIDADE A DOENÇA
FAMILIA
GENÉTICA MÉDICA
HAPLOTIPOS
HANSENIASE TUBERCULOIDE
HANSENIASE TUBERCULOIDE
MATEMATICA
MODELOS GENÉTICOS
MODELOS ESTATISTICOS
PAIS
PROBABILIDADE
Localização:BR191.1; 06636/s



página 1 de 1
   


Refinar a pesquisa
  Base de dados : HANSEN Formulário avançado   
Pesquisar por : Formulário livre   

    Pesquisar no campo  
1  
2
3
 
           



Search engine: iAH v2.6.1 powered by WWWISIS

BIREME/PAHO/WHO - Latin American and Caribbean Center on Health Sciences Information